DEKKERS MARIJN E 4
4 · Cerevel Therapeutics Holdings, Inc. · Filed Jun 7, 2024
Insider Transaction Report
Form 4
DEKKERS MARIJN E
Director
Transactions
- Award
Common Stock
2024-06-05+10,461→ 42,283 total
Holdings
- 402,326(indirect: See footnote)
Common Stock
Footnotes (2)
- [F1]The shares reported in this transaction represent Restricted Stock Units ("RSUs") granted under the Cerevel Therapeutics Holdings, Inc. 2020 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of the Issuer's common stock. 100% of the RSUs subject to this grant shall vest upon the earlier of: (i) the one-year anniversary of the Grant Date, or (ii) the 2025 annual meeting of stockholders of the Company.
- [F2]Represents shares held by Novalis LifeSciences Investments I, L.P. ("Novalis LifeSciences"). The Reporting Person, the Manager of the general partner of Novalis LifeSciences, has sole voting and dispositive power over the shares held by Novalis LifeSciences and, as a result, may be deemed to share beneficial ownership of the shares held by Novalis LifeSciences. The Reporting Person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.